Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07504471RecruitingPhase 2
Bicarbonate plus chemo and immunotherapy for pancreatic cancer liver spread
This trial tests adding sodium bicarbonate to a chemotherapy plus immunotherapy regimen for pancreatic cancer that has spread to the liver. The goal is to see if this combination helps shrink tumors and improves outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07504510Recruiting
Exclusive liquid nutrition for active Crohn's disease
This trial tests whether a special liquid-only diet (exclusive enteral nutrition) can help people with active Crohn's disease, including those with complications like fistulas or narrowing of the intestine. It aims to improve nutrition and reduce disease activity without medication.
Guangzhou, GuangdongAges 18 years+ - NCT07504731Recruiting
Effect of body position and breathing support on lung function
This study tests how changing a patient's body tilt and adjusting a ventilator's settings can help open up collapsed parts of the lungs. It may help patients with severe lung failure.
Nanjing, JiangsuAges 18 years+ - NCT07504757Recruiting
Leishmaniasis in Children: A Study
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
Florence, TuscanyAges Up to 17 years - NCT07505173RecruitingPhase 2
Targeted radiation plus osimertinib for brain metastases from EGFR-mutant lung cancer
This trial tests adding a brain-sparing radiation technique to the targeted therapy drug osimertinib for people with EGFR-mutant lung adenocarcinoma that has spread to the brain and is causing symptoms. The goal is to see if this combination can better control the brain tumors while protecting the hippocampus, a key memory area.
TianjinAges 18–75 - NCT07505472RecruitingPhase 2/Phase 3
Short radiation plus chemo and immunotherapy for high-risk rectal cancer
This trial tests a new approach for people with locally advanced rectal cancer that has high-risk features. It combines short-course radiation with chemotherapy (CapeOX) and the immunotherapy drug toripalimab, with or without another drug called surufatinib, before surgery. The goal is to see if adding these drugs helps shrink the tumor and improve outcomes.
Changchun, JilinAges 18–75 - NCT07505667Recruiting
Yiyuancong for sudden hearing loss
This trial tests a medicine called Yiyuancong for people who recently lost hearing in one ear suddenly. If you are between 18 and 60 years old and your hearing loss started within the last 3 days, this study may be an option.
Guangzhou, GuangdongAges 18–60 - NCT07505719Recruiting
AI vs. original education for parents
This trial tests whether AI-simplified educational materials help parents understand their child's condition better than the original materials. It includes parents of children treated at Hospital for Special Surgery.
New York, New YorkAges 18 years+ - NCT07505758Recruiting
Recovery after surgery in adults 80 and older
This study looks at how well adults aged 80 or older recover after planned surgery that requires an overnight hospital stay. The goal is to understand recovery using a simple questionnaire.
Barcelona, BarcelonaAges 80 years+ - NCT07505862Recruiting
Testing AI vs. Human Questions for Medical Licensing Exam
This study checks if questions written by artificial intelligence (AI) are as good as those written by people for the Chinese medical licensing exam. It could help improve how future doctors are tested.
Guangzhou, GuangdongAges 18–60 - NCT07505927Recruiting
Acupuncture for slow stomach emptying after stomach surgery
This study tests whether acupuncture can help improve slow stomach emptying that sometimes happens after partial stomach removal surgery. It's for people who have this specific problem and want to try a non-drug option.
Jinan, ShandongAges 18–80 - NCT07506005Recruiting
Stapler placement study for colorectal surgery
This trial tests if the placement of the stapler spike during colorectal surgery affects bleeding where the bowel is joined. It may help guide safer stapling techniques.
LinzAges Any age - NCT07506109RecruitingPhase 2
Study of sintilimab, ipilimumab, cetuximab, and dabrafenib for advanced colorectal cancer
This trial tests a combination of four drugs for people with a specific type of advanced colorectal cancer that has a BRAF V600E mutation and is microsatellite stable. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07506356Recruiting
Stomach emptying in diabetes patients on GLP-1 drugs
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
Geneva, Canton of GenevaAges 18 years+ - NCT07506369Recruiting
How pancreatic polypeptide affects appetite fullness in healthy men
This study tests whether pancreatic polypeptide (a natural hormone) changes how full you feel when combined with another hormone called amylin. It may help us understand appetite control in healthy people.
Hellerup, Capital RegionAges 18–65 - NCT07507201RecruitingEarly Phase 1
Car-T cells for autoimmune diseases like lupus
This trial tests whether specially-engineered immune cells (CAR-T cells) can help people with certain autoimmune diseases that haven't gotten better with standard treatments. The cells are designed to target and remove faulty B cells that are causing the immune system to attack the body.
Hangzhou, ZhejiangAges 3 years+ - NCT07508410Recruiting
Mulligan vs Myofascial Release for Neck-Related Headaches
This study compares two hands-on therapy techniques—Mulligan mobilization and myofascial release—to see which works better for headaches that start from the neck. If you have neck pain on one side and headaches that get worse with movement, this trial may help you find relief.
KonyaAges 18–65 - NCT07508618RecruitingPhase 4
Qidong Yixin Granule for preventing atrial fibrillation after ablation
This trial tests whether a traditional Chinese medicine granule, Qidong Yixin, can help prevent atrial fibrillation from coming back after a heart ablation procedure. It is for people with persistent atrial fibrillation who have not had good results from other heart rhythm medications.
HangzhouAges 18–80 - NCT07508605RecruitingPhase 1/Phase 2
CD19/CD20 CAR/TRuC-T cells for lymphoma that returned or didn't respond
This trial tests a new type of immune cell therapy that targets two markers (CD19 and CD20) on your lymphoma cells. It is for people whose lymphoma came back or didn't respond to previous treatments, including CD19 CAR-T therapy.
Shenzhen, GuangdongAges 18–75 - NCT07508813Recruiting
Digital system to check and reduce disability risk in older adults
This study tests a digital tool that helps assess and reduce the risk of disability in older adults living in the community. It uses a smartphone app to monitor and guide personalized interventions.
Hangzhou, ZhejiangAges 65 years+ - NCT07508852RecruitingPhase 1/Phase 2
PET scan for small cell lung cancer diagnosis
This study uses a special PET scan (68Ga-PFD3) to take pictures of small cell lung cancer tumors. The goal is to see if this scan can help doctors better diagnose and evaluate the cancer, which may guide treatment decisions.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07509086RecruitingPhase 2
Enhanced CAR-T therapy for relapsed multiple myeloma
This trial tests a new type of immune cell therapy (CAR-T cells boosted with a protein called IL-15) for people with multiple myeloma or plasma cell leukemia that has not responded to standard treatments or has come back. The goal is to see if these enhanced cells can better fight the cancer.
Changchun, JilinAges 18–80 - NCT07509333Recruiting
Team-based treatment plan for older lung cancer patients
This trial is for older adults (60–90) with any stage of the two most common types of lung cancer (NSCLC or SCLC). It uses a team of experts to create a personalized treatment plan and closely monitors your health and quality of life.
Chengdu, SichuanAges 60–70 - NCT07509359Recruiting
Comparing two vein approaches for midline catheters in children
This trial compares two ways to place a midline catheter (a type of IV line) in children to see which works better. If your child needs long-term IV access during or after surgery, this study may help find the safest and most effective method.
Seoul, Soul-t'ukpyolsiAges 2–17
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,622 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.